385 related articles for article (PubMed ID: 24614376)
1. Energy metabolism and drug efflux in Mycobacterium tuberculosis.
Black PA; Warren RM; Louw GE; van Helden PD; Victor TC; Kana BD
Antimicrob Agents Chemother; 2014 May; 58(5):2491-503. PubMed ID: 24614376
[TBL] [Abstract][Full Text] [Related]
2. Unique structural and mechanistic properties of mycobacterial F-ATP synthases: Implications for drug design.
Kamariah N; Ragunathan P; Shin J; Saw WG; Wong CF; Dick T; Grüber G
Prog Biophys Mol Biol; 2020 May; 152():64-73. PubMed ID: 31743686
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid accumulation in Mycobacterium smegmatis is modulated by proton motive force-driven and ATP-dependent extrusion systems.
Choudhuri BS; Sen S; Chakrabarti P
Biochem Biophys Res Commun; 1999 Mar; 256(3):682-4. PubMed ID: 10080959
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].
Özgür D; Ersoy L; Ülger M; Tezcan Ülger S; Aslan G
Mikrobiyol Bul; 2023 Apr; 57(2):207-219. PubMed ID: 37067206
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
Danilchanka O; Mailaender C; Niederweis M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2503-11. PubMed ID: 18458127
[TBL] [Abstract][Full Text] [Related]
6. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
[TBL] [Abstract][Full Text] [Related]
7. Critical discussion on drug efflux in Mycobacterium tuberculosis.
Remm S; Earp JC; Dick T; Dartois V; Seeger MA
FEMS Microbiol Rev; 2022 Feb; 46(1):. PubMed ID: 34637511
[TBL] [Abstract][Full Text] [Related]
8. Experimental Evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) Uncoupler Carbonyl Cyanide
Griffith JM; Basting PJ; Bischof KM; Wrona EP; Kunka KS; Tancredi AC; Moore JP; Hyman MRL; Slonczewski JL
Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30578262
[TBL] [Abstract][Full Text] [Related]
9. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Ramón-García S; Martín C; Thompson CJ; Aínsa JA
Antimicrob Agents Chemother; 2009 Sep; 53(9):3675-82. PubMed ID: 19564371
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis.
Aínsa JA; Blokpoel MC; Otal I; Young DB; De Smet KA; Martín C
J Bacteriol; 1998 Nov; 180(22):5836-43. PubMed ID: 9811639
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics.
Machado D; Azzali E; Couto I; Costantino G; Pieroni M; Viveiros M
Future Microbiol; 2018 Sep; 13():1383-1402. PubMed ID: 30259757
[TBL] [Abstract][Full Text] [Related]
12. In Silico Approach for Phytocompound-Based Drug Designing to Fight Efflux Pump-Mediated Multidrug-Resistant Mycobacterium tuberculosis.
Biswas SS; Browne RB; Borah VV; Roy JD
Appl Biochem Biotechnol; 2021 Jun; 193(6):1757-1779. PubMed ID: 33826064
[TBL] [Abstract][Full Text] [Related]
13. An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis.
Kelam LM; Wani MA; Dhaked DK
Prog Biophys Mol Biol; 2023; 180-181():87-104. PubMed ID: 37105260
[TBL] [Abstract][Full Text] [Related]
14. 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain.
Jeon AB; Ackart DF; Li W; Jackson M; Melander RJ; Melander C; Abramovitch RB; Chicco AJ; Basaraba RJ; Obregón-Henao A
Sci Rep; 2019 Feb; 9(1):1513. PubMed ID: 30728417
[TBL] [Abstract][Full Text] [Related]
15. A piperidinol-containing molecule is active against
Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
[No Abstract] [Full Text] [Related]
16. Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis.
Yamamoto K; Nakata N; Mukai T; Kawagishi I; Ato M
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408221
[TBL] [Abstract][Full Text] [Related]
17. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
Rai D; Mehra S
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0026221. PubMed ID: 34424047
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan.
Kanji A; Hasan R; Ali A; Zaver A; Zhang Y; Imtiaz K; Shi W; Clark TG; McNerney R; Phelan J; Rao S; Shafiq S; Hasan Z
Tuberculosis (Edinb); 2017 Dec; 107():20-30. PubMed ID: 29050768
[TBL] [Abstract][Full Text] [Related]
20. Potential of Mycobacterium vanbaalenii as a model organism to study drug transporters of Mycobacterium tuberculosis, Mycobacterium marinum and Mycobacterium ulcerans: homology analysis of M. tuberculosis drug transporters among mycobacterial species.
Gupta AK; Katoch VM; Chauhan DS; Lavania M
Infect Genet Evol; 2012 Jun; 12(4):853-6. PubMed ID: 22127144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
